Hyperkalemia in Diabetes Mellitus Setting

Autor(es)

Goia-Nishide, Kleber ; Coregliano-Ring, Lucas ; Bevilaqua Rangel, Erika

• Tipo de documento: Artigo Científico
• Fonte: DISEASES; v. 10, n. 2, p. 17-pg., 2022-06-01.

Resumo

Diabetes mellitus is a global health problem that affects 9.3% of the worldwide population and is associated with a series of comorbidities such as heart failure (HF) and chronic kidney disease (CKD). Diabetic patients, especially those with associated CKD, are more susceptible to present potassium disorders, in particular hyperkalemia due to kidney disease progression or use of renin-angiotensin-aldosterone blockers. Hyperkalemia is a potentially life-threatening condition that increases the risk of cardiac arrhythmia episodes and sudden death, making the management of potassium levels a challenge to reduce the mortality rate in this population. This review aims to briefly present the potassium physiology and discuss the main conditions that lead to hyperkalemia in diabetic individuals, the main signs, symptoms, and exams for the diagnosis of hyperkalemia, and the steps that should be followed to manage patients with this potentially life-threatening condition. (AU)

• Processo FAPESP: 21/02216-7 - Tratamento combinado com empagliflozina, restrição calórica, células-tronco mesenquimais e Klotho para estacionar a progressão da doença renal diabética e acelerar a recuperação da lesão renal aguda
• Beneficiário: Érika Bevilaqua Rangel
• Modalidade de apoio: Auxílio à Pesquisa - Regular